These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1395739)

  • 1. Changes in hospital admissions pattern in patients with human immunodeficiency virus infection in the era of Pneumocystis carinii prophylaxis.
    Chien SM; Rawji M; Mintz S; Rachlis A; Chan CK
    Chest; 1992 Oct; 102(4):1035-9. PubMed ID: 1395739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of morbidity and mortality in AIDS patients on Pneumocystis carinii prophylaxis who died during hospital admission: a report of 50 diseased patients.
    Hentzen BT; Schreij G
    Neth J Med; 1996 Sep; 49(3):101-5. PubMed ID: 8854672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia.
    Gallant JE; McAvinue SM; Moore RD; Bartlett JG; Stanton DL; Chaisson RE
    Chest; 1995 Apr; 107(4):1018-23. PubMed ID: 7705108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group.
    McIvor RA; Berger P; Pack LL; Rachlis A; Chan CK
    Chest; 1996 Jul; 110(1):141-6. PubMed ID: 8681618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia.
    Turner BJ; Markson L; Cocroft J; Cosler L; Hauck WW
    J Gen Intern Med; 1998 Jan; 13(1):16-23. PubMed ID: 9462490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in HIV-related hospital admissions and their impact on hospital resource utilization in Ontario.
    Hyland MJ; Bailey G; Rawji M; Peck LL; Hyland RH; Chan CK
    Clin Invest Med; 1997 Apr; 20(2):95-101. PubMed ID: 9088665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of intravenous pentamidine as prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection.
    Schroeder KE; Barton SE
    Int J STD AIDS; 1994; 5(5):353-5. PubMed ID: 7819354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
    Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
    Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
    Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
    Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
    N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
    Fisher RG; Nageswaran S; Valentine ME; McKinney RE
    AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia.
    Fahy JV; Chin DP; Schnapp LM; Steiger DJ; Schaumberg TH; Geaghan SM; Klein JS; Hopewell PC
    Am Rev Respir Dis; 1992 Oct; 146(4):844-8. PubMed ID: 1416408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
    Cheung TW; Matta R; Neibart E; Hammer G; Chusid E; Sacks HS; Szabo S; Rose D
    Clin Infect Dis; 1993 Jan; 16(1):22-5. PubMed ID: 8448314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.